| RS2136571455 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Platyspondylic dysplasia, Torrance type |
| RS2136571464 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136571484 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2136571492 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136571551 |
COL2A1
|
Health Risk |
Pathogenic |
Kniest dysplasia, Kniest dysplasia |
| RS2136571594 |
COL2A1
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2136572656 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136573333 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136573942 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136573975 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136574120 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136574184 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136574259 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136575516 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136575582 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136575653 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Strudwick type |
| RS2136575705 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136575877 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136576211 |
COL2A1
|
Health Risk |
Pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2136576254 |
COL2A1
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2136577028 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136577094 |
COL2A1
|
Health Risk |
Likely pathogenic |
Kniest dysplasia, Kniest dysplasia |
| RS2136577123 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136577158 |
COL2A1
|
Health Risk |
Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2136577175 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136577259 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136579057 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136579085 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136579152 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS2136579397 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136579443 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2136579628 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136582679 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS2136584562 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2136587563 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136587619 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136587632 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome, type I |
| RS2136587657 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2136587685 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloperipheral dysplasia, Spondyloperipheral dysplasia |
| RS2136590070 |
COL2A1
|
Health Risk |
Pathogenic |
Kniest dysplasia, Kniest dysplasia |
| RS2136590109 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136590361 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Strudwick type |
| RS2136590384 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136590405 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome, type I |
| RS2136590607 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136595276 |
ETV6
|
Health Risk |
Pathogenic |
— |
| RS2136596089 |
ETV6
|
Health Risk |
Likely pathogenic |
ETV6-related disorder, ETV6-related disorder |
| RS2136596563 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Basal cell carcinoma |
| RS2136602093 |
ETV6
|
Health Risk |
Pathogenic |
— |
| RS2136602130 |
ETV6
|
Health Risk |
Pathogenic |
— |
| RS2136602321 |
ETV6
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombocytopenia 5, Inborn genetic diseases |
| RS2136604599 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloperipheral dysplasia, Spondyloperipheral dysplasia |
| RS2136604676 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136604691 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136604776 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136604937 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136605023 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS2136605039 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136605096 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2136607401 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2136607614 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2136607793 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136607887 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2136608011 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136608035 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4 |
| RS2136609285 |
COL2A1
|
Health Risk |
Pathogenic |
Kniest dysplasia, Kniest dysplasia |
| RS2136609413 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136610457 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136610618 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136610684 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloperipheral dysplasia, Spondyloperipheral dysplasia |
| RS2136610697 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136611559 |
ATM
|
Health Risk |
Likely pathogenic |
Abnormal central motor function, Ataxia-telangiectasia syndrome |
| RS2136612635 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136612683 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136612771 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136613666 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136614884 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136615248 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136616143 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136616311 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136616399 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2136616554 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136618158 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136618285 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136618395 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136618963 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136618972 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136619125 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS2136619163 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136619174 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136621947 |
COL2A1
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2136622208 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2136622365 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136625913 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136625993 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136626176 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136626297 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2136626415 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 collagenopathy, Type 2 collagenopathy |
| RS2136626600 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2136626631 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |